Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Capital Expenditures: 2010-2019

Historic Capital Expenditures for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to -$101,000.

  • EyePoint Pharmaceuticals' Capital Expenditures fell 380.95% to -$101,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $169,000, marking a year-over-year increase of 29.01%. This contributed to the annual value of $4.1 million for FY2024, which is 16.34% up from last year.
  • As of Q4 2019, EyePoint Pharmaceuticals' Capital Expenditures stood at -$101,000, which was down 155.49% from $182,000 recorded in Q1 2019.
  • EyePoint Pharmaceuticals' 5-year Capital Expenditures high stood at $182,000 for Q1 2019, and its period low was -$101,000 during Q4 2019.
  • For the 3-year period, EyePoint Pharmaceuticals' Capital Expenditures averaged around $46,444, with its median value being $44,000 (2018).
  • Within the past 5 years, the most significant YoY rise in EyePoint Pharmaceuticals' Capital Expenditures was 18,300.00% (2019), while the steepest drop was 380.95% (2019).
  • EyePoint Pharmaceuticals' Capital Expenditures (Quarterly) stood at $25,000 in 2015, then plummeted by 80.00% to $5,000 in 2016, then skyrocketed by 171.74% to $64,000 in 2017, then soared by 70.31% to -$21,000 in 2018, then crashed by 380.95% to -$101,000 in 2019.
  • Its Capital Expenditures stands at -$101,000 for Q4 2019, versus $182,000 for Q1 2019 and -$21,000 for Q4 2018.